Earnings calls / INDIGOPNTS · August 14, 2026

Indigo Paints Ltd Q1 FY27 Earnings Call Summary

Indigo Paints Q1 FY27 standalone revenue was ₹350 crore, up 18.7% YoY, with EBITDA margin at 17.7% and PAT at ₹42.4 crore, up 60.7%. The beat came from operating leverage, tighter discretionary spend, and dealer micro-segmentation under the new CBO, not pricing. Management called the growth not aggressive enough, and guides to higher trade and influencer spend in Q2, Jodhpur plant commissioning before festive season, and no significant capex for three years. Risks: raw material volatility after March's Iran-related price spike, Q2 seasonal margin pressure, and Apple Chemie margin normalization only by Q3 FY27.

Revenue
Margin
Demand
Guidance
Tone
Metrics raised 1
  • Top line growth ambition raised: management to be 'substantially ahead of industry' with more aggressive Q2 trade and influencer spends (prior stance: growth 'was not aggressive enough', did not commit to specific multiple)
Metrics cut 1
  • CAPEX guidance cut: no significant CAPEX for next 3 years, concluding the Jodhpur plant investment cycle (prior: ongoing significant CAPEX for plant and network expansion)

Event Participants

Executives

5 Hemant Jalan (Chairman & Managing Director), Aishwarya Pratap Singh (Chief Business Officer), Srihari Santhakumar (GM Finance & IR), Suresh Babu (COO), Hemant Jason Humani (CFO)

Analysts

8 Abneesh Roy (Nuvama Wealth Management), Amit Purohit (Elara Capital), Dev (ithoughtPMS), Mihir Shah (Nomura), Prakash Kapadia (Kapadia Financial Services), Prithvi Raj (Unifi Capital), Sonal Minhas (Prescient Capital), Yasser Lakdawala (M3 Investment)

Financials & KPIs

Metric Reported Commentary
Standalone Revenue ₹350 crores +18.7% YoY (₹295 crores in Q1 FY26); first double-digit growth quarter in ~2 years, with double-digit volume and value growth across all four product categories
Consolidated Revenue ₹369.7 crores +19.7% YoY; includes Apple Chemie subsidiary contribution of ₹19.7 crores (+40% YoY)
Volume Growth Double-digit across all categories Primers/distempers +18%, putti/cement paint +14%, emulsion +12.5%, enamel/wood coating +10%
Gross Margin 45.3% Slightly lower than Q1 FY26; remains well ahead of listed paint industry average, a lead sustained for many years
EBITDA ₹61.9 crores (standalone) +42% YoY vs ₹43.6 crores; margin expanded 290 bps from 14.8% to 17.7% — healthiest Q1 in four years, driven by operating leverage and tighter discretionary spend control
PAT ₹42.4 crores (standalone) +60.7% YoY vs ₹26.4 crores; margin expanded from 8.8% to 11.8%, partially aided by mark-to-market gain on treasury income
Consolidated EBITDA ₹62 crores +40% YoY, margin 16.8%
Consolidated PAT ₹41.7 crores +60% YoY, margin 11%
A&P Spend 4.3% of revenue Down from 6.8% in Q1 FY26; strategic IPL timeout redirected funds to painter/contractor engagement, influencer partnerships, and digital advertising
Active Dealers ~19,400 Up ~800 YoY; network activation focus under CBO's segmentation strategy
Active Tinting Machines ~12,400 Up ~1,100 YoY; management highlights this as a firmer measure of dealer relationship depth vs dealer count
Apple Chemie Revenue ₹19.7 crores +40% YoY vs ₹14 crores; margin compression due to elevated input costs and high-cost inventory purchases

Geographic & Segment Commentary

  • Primers & Distempers: Value growth of ~30% and volume growth exceeding 18%, leading all categories. Driven by increased dealer activation and category-level portfolio strategies implemented in Q1.
  • Putti & Cement Paint: Value growth upwards of 21%, volume growth close to 14%. Benefited from trade-focused aggression in the semi-urban and rural demand centers.
  • Enamel & Wood Coating: Value grew 17.5%, volume 10%. New focus area: company recruiting specialized sales team for 2-pack polyurethane wood coatings segment (₹9,000 crore market), with product launches planned for September–October after in-house product development.
  • Emulsion (largest category): Value grew >17%, volume ~12.5%. Premium-end share building continues gradually through influencer work; management notes premium segment share gains are inherently slow due to brand equity requirements.
  • Apple Chemie (subsidiary): Revenue ₹19.7 crores (+40% YoY); profitability compressed due to B2B pricing limitations during input cost spikes and consumption of high-cost inventory procured at peak prices. Management views both as transitory — margins expected to improve through Q2 and normalize by Q3. Indigo acquiring additional 11% stake (aggregate to 62%) as confidence expression.

Company-Specific & Strategic Commentary

  • Accelerated Top Line Strategy: Management explicitly stated the growth achieved was "not aggressive enough" since bottom line grew faster than top line. Will be more aggressive on trade and influencer spends in Q2 to widen the gap vs industry growth. Bottom line "will take care of itself" over time.
  • IPL Advertising Timeout: Strategic withdrawal was purely due to Iran war supply chain uncertainty in March — not competitive intensity or Dhoni's participation. Management felt advertising while unsure of material supply was "foolhardy"; with hindsight, they acknowledge they could have stayed. Funds redirected to measurable digital channels; annual brand investment commitment undiminished.
  • Distribution Deepening: New CBO (Aishwarya Pratap Singh, ex-ITC/Dabur) implemented micro-segmentation of dealer clusters (big/small/opportunity-driven) and category-level growth strategies (brand building vs influencer vs trade-focused). Three months into implementation; results visible in Q1; focus on execution through festive season.
  • Jodhpur Capacity Commissioning: Water-based plant (90,000 KL/annum) in final commissioning stages, trial production expected second half of August — comfortably ahead of festive season. Delays attributed to tardy civil contractor, not raw material issues. Solvent-based plant already producing. Improves lead times and freight economics for northern, eastern, central India.
  • CapEx Cycle Conclusion: With Jodhpur water-based facility commissioned, no significant CAPEX anticipated for next three years. Incremental revenue should translate to free cash flows at "considerably better rate" than last five years.
  • Wood Coatings Expansion: New specialized sales team recruited for select high-potential wood coating markets; in-house developed 2-pack polyurethane products comparable to best available; phased launch September–October. Currently negligible presence in this ~₹9,000 crore segment.
  • Apple Chemie Stake Increase: Acquiring additional 11% per original agreement terms, taking Indigo's holding to 62%; promoters retain 38% and continue driving growth.
  • ESG/CSR: Solar capacity 350 kW (Pune/Cochin), planning 1,200 kW more at Jodhpur; 240+ government schools painted via Indigo Seva Utsav; Painter Health Benefit program covers 30,000+ families; 1,250+ contractors trained; 420+ underprivileged girls supported via EDUCARE.

Guidance & Outlook

Metric Guidance / Outlook Commentary
Top Line Growth Substantially ahead of industry; more aggressive in Q2 Management declined to commit to "2x industry" formula — depends on industry base (2x at 15% industry growth is unrealistic; at 5% growth, better than 2x expected). Focus on widening gap quarterly.
Q2 Margins No specific guidance — too volatile Raw material price swings after March spiked prices and strategic trade spends make prediction "fuzzy." Q2 is traditionally worst margin quarter due to seasonal mix deterioration (exterior paints slow during monsoons). Management suggests evaluating H1 FY27 vs H1 FY26 margins for stability.
Apple Chemie Margins Normalize by Q3 FY27 High-cost inventory consumed through Q2; gross margins expected to improve during Q2 and return to normal level by Q3.
Price Cuts Possible post-Diwali If raw material prices stabilize at current levels, industry may cut prices post-Diwali; trade discounts would adjust proportionately, keeping net sale margins broadly flat.
Capex No significant CAPEX for next 3 years Plant capacity and network now in place; free cash flow conversion expected to improve materially.
Differentiated Products Maintain 28–30% share of revenue Management sees 35%+ as over-ambitious; gradual inch-up from ~25-26% at IPO to ~29.5% currently is satisfactory.

Risks & Constraints

Risk Context
Raw Material Volatility Prices rose steeply in March (Iran war supply disruption), have retreated from peaks but remain elevated and volatile. Industry suspended trade discounts in first half of Q1 due to uncertainty. Mid-East issue "has slowly gone away from the news" but alternative sources/routes for raw materials now secured — however risk of renewed disruption if conflict escalates.
Q2 Seasonal Margin Pressure Q2 traditionally worst quarter for paint industry margins due to monsoon-driven product mix deterioration (premium and exterior products take a backseat). Management flagged margins may be lower in Q2 vs Q1 but sees no major industry problem; suggests H1 comparison more meaningful.
Apple Chemie Margin Compression Transitory but real — B2B model limited pricing power during input spikes; high-cost inventory procured at peak prices weighed on COGS. Managing risk by increasing stake to 62% (confidence signal). Recovery expected Q3.
Competitive Landscape JSW Paints' acquisition of Axonobel pending formal merger — no visible ground-level change yet. Birla Opus entry (~2.5 years ago) has "subsided" and stabilized into base. Market leader benefits disproportionately from steep, frequent price hikes (dealers stock up on leading brand first).
Civil Construction Delays Jodhpur plant commissioning delayed significantly by tardy civil contractor (~1 year of equipment waiting). Legacy plant still operational if any further slippage — adequate capacity to service demand.
Market Leader Advantage In premium product segments, market leader's share is disproportionately high (est. ~75% at premium end vs ~50% overall). Premium share gains for smaller players are inherently slow — brand building takes extended time.

Q&A Highlights

CBO Strategy & FMCG Learnings (Abneesh Roy, Nuvama)

  • Question: What's going right and what can be improved as CBO with 20-year FMCG background (ITC, Dabur)?
  • Answer: (Aishwarya Pratap Singh) Focused on two areas: (1) maximizing existing distribution network of ~19,400 dealers through micro-segmentation of dealer clusters (big/small/opportunity-driven) — activated more dealers working closely rather than only big dealers; (2) category-level growth strategy — divided portfolio by sensitivity (brand building vs influencer vs trade-focused) and injected appropriate inputs per cluster. Third area: people/training investment. Working well — results visible after three months; execution priority continues through festive season; more brand building action expected Q2.

Gap with Market Leader & IPL Timeout (Abneesh Roy, Nuvama)

  • Question: Your sales growth is impressive but the gap vs market leader hasn't widened enough. Was mass media (IPL) a missed opportunity?
  • Answer: (Hemant Jalan) Steep price increases in Q1 — unprecedented in 25 years — always benefit the market leader most (dealers stock up on leading brand first). Management acknowledges "we did not do enough" — bottom line growing faster than top line proves it. First 45 days of Q1 were spent just securing raw materials — industry-wide suspension of trade discounts. The IPL decision was purely due to Iran war supply uncertainty — not Dhoni, not competitive advertising intensity. With hindsight, could have stayed in IPL, but funds are being redirected at increased pace in coming months. Advertising expense timing in a single quarter "doesn't matter very much" for a company advertising steadily for 12-13 years.

Demand Recovery & Profitable Growth (Prakash Kapadia, Kapadia Financial Services)

  • Question: Is this low base effect or real demand coming back? Will we maintain outperformance historically seen?
  • Answer: (Hemant Jalan) Demand suppressed across all consumer categories for two fiscals (HUL, Nestle included). Paint industry showed progressive improvement: Q3 FY26 better than Q1/Q2, Q4 better, Q1 FY27 better still — "demand is back to near normal growth conditions." Confident of growing faster than industry. Profitability has never been concern; margin expansion "not a primary goal" — if it happens as byproduct, fine, but there could be quarters when margins are lower than prior year. Focus is on top line growth and market share gain.

July/August Sales Momentum & Margin Outlook (Mihir Shah, Nomura)

  • Question: Any destocking impact in Q2 after Q1 upstocking? And on gross/EBITDA margin with high-cost inventory, any guidance?
  • Answer: (Hemant Jalan) If any channel overstocking occurred from price hikes, it would have been with the market leader, not Indigo. July was "actually a very good month" — top line momentum maintained or slightly better than Q1. No devastating rain issues in any part of the country. No concrete Q2 margin guidance — "roller coaster ride" in RM prices and selling prices makes prediction difficult; Q2 traditionally worst margin quarter due to seasonal mix; recommends evaluating H1 vs H1. Regarding further price increases: "as of now, no" — but dependent on Middle East situation and US President's decisions.

Product Launches & Premium Positioning (Sonal Minhas, Prescient Capital)

  • Question: Does growth entail newer, more premium products? How does Indigo build premium emulsion products comparable to Ultima Pro?
  • Answer: (Hemant Jalan) Product portfolio is already complete — Indigo has equivalent or better products vs competition on both exterior and interior. The gap is in premium-end share: market leader holds ~75% share of premium segment vs ~50% overall. Premium share gains happen slowly through influencer work and brand building — "not that you're suddenly going to increase drastically." Confirmed new area: wood coatings (2-pack polyurethane segment — large, high-growth, profitable), developed in-house, specialized sales team recruited, phased launch Sept–Oct.

Jodhpur Facility OPEX & Competitive Landscape (Yasser Lakdawala, M3 Investment)

  • Question: What running cost should get absorbed from Jodhpur plant? And how does JSW/Axonobel deal change competitive intensity?
  • Answer: (Hemant Jalan) OPEX won't change materially — Jodhpur already had water-based plant (since 2000-01); legacy plant being scrapped, manpower carries forward. No significant new cost. On competition: JSW and Axonobel continue operating separately, no formal merger announced; no visible ground-level change. Birla Opus entry's "brouhaha has subsided" and stabilized into base. "No change in competitive intensity" — paint sector has always been highly competitive; it's built into expectations. Differentiated product portfolio unchanged at 29-30% of revenue — "no new differentiated product on the anvil."

Jodhpur Plant Delay & Capacity Ramp-Up (Dev, ithoughtPMS)

  • Question: Why pushed from June to August? How should we see ramp-up before festive?
  • Answer: (Hemant Jalan) Delay not related to raw materials — civil construction contractor was "extremely tardy"; equipment arrived almost a year ago and was waiting. Difficult to change contractors mid-project. Weak demand in last two years meant no urgency pressure — legacy plant serviced demand. Civil work now complete; equipment commissioning underway; trial production expected within ~10 days; plant expected stabilized within a month, in time for October festive pressure. Even with unexpected month delay, legacy plant capacity adequate.

Margin Philosophy & 2x Industry Growth Guidance (Prithvi Raj, Unifi Capital)

  • Question: Can we assume margins flattish or slightly higher? Do you stick with 2x industry growth guidance?
  • Answer: (Hemant Jalan) Aiming for aggressive top line growth; if gross margins drop by couple of percentage points, no problem — company has consistently had highest gross margin and second-best EBITDA margin in industry. 1% movement either direction on EBITDA "is not going to make or break the company." 2x guidance depends on industry base: at 15% industry growth, 2x is difficult; at 5%, better than 2x expected. "There should be a substantial gap" — hesitant to give concrete number. Bottom line changes acceptable once growth slows, "which is not foreseeable in the next few years."

Wood Coatings & Differentiated Portfolio Share (Amit Purohit, Elara Capital)

  • Question: Is wood coatings a differentiated product? Can differentiated portfolio share grow to 33-35%?
  • Answer: (Hemant Jalan) Wood coatings launches are NOT differentiated products — they're filling a product gap (2-pack polyurethane segment where Indigo had no presence). Requires specialized sales team due to architect/contractor influence dynamics. Market estimated ~₹9,000 crores. On differentiated share: IPO-era share was ~25-26%, now ~29.5%, growing gradually faster than me-too products. Moving to 35% would be "a little over ambitious" — 28-30% band is satisfactory.

Key Takeaway

Indigo Paints delivered its strongest quarter in two years with standalone revenue of ₹350 crores (+18.7% YoY), the first double-digit growth quarter since pre-FY25 slowdown, with double-digit gains across all product categories and record Q1 EBITDA margin of 17.7%. Management attributed performance to operating leverage, tighter discretionary cost control, and a new distribution strategy under CBO Aishwarya Pratap Singh focused on dealer micro-segmentation and category-specific investment approaches. The paint demand environment is deemed "back to near normal growth conditions" with Q3-Q4 FY26 showing progressive industry recovery. Strategy pivots to aggressive top line expansion — management explicitly stated Q1 growth "was not aggressive enough" and Q2 will see higher trade and influencer spends, accepting potential margin trade-offs. Key catalysts: Jodhpur water-based plant (90,000 KL) commissioning ahead of festive season, closure of the CAPEX cycle (no significant CAPEX for 3 years), wood coatings expansion into the ~₹9,000 crore 2-pack PU segment, and Apple Chemie stake increase to 62%. Watch points include raw material price volatility post-Iran conflict, Q2 seasonal margin pressure, Apple Chemie margin normalization by Q3, and whether the gap vs industry growth widens as guided.

What you get with InvestorStack

Institutional-grade research, built for individual investors.

  • Research Reports for every listed Indian company
  • Detailed valuation models
  • Growth triggers, Risks, KPIs, Read between the lines
  • Scans, One pagers, Industry research reports
Try for free